BRIEF-GlaxoSmithkline and Innoviva announces positive impact results for Trelegy in COPD
September 20, 2017 at 02:16 AM EDT
* CO, INNOVIVA REPORT POSITIVE HEADLINE RESULTS FROM STUDY SHOWING SINGLE INHALER TRIPLE THERAPY TRELEGY ELLIPTA REDUCED COPD EXACERBATIONS
